Journal of Dentistry
Volume 38, Issue 1 , Pages 10-15 , January 2010

Levels of salivary IgA antibodies to Candida spp. in HIV-infected adult patients: A systematic review

  • Luciana Pomarico

      Affiliations

    • Department of Paediatric Dentistry and Orthodontics, School of Dentistry, Federal University of Rio de Janeiro, Brazil
    • Corresponding Author InformationCorresponding author at: Praia do Flamengo, 370/202 – Flamengo, 22210-030 Rio de Janeiro, RJ, Brazil. Fax: +55 21 2551 4354.
  • ,
  • Ivete Pomarico Ribeiro de Souza

      Affiliations

    • Department of Paediatric Dentistry and Orthodontics, School of Dentistry, Federal University of Rio de Janeiro, Brazil
  • ,
  • Glória Fernanda Barbosa de Araújo Castro

      Affiliations

    • Department of Paediatric Dentistry and Orthodontics, School of Dentistry, Federal University of Rio de Janeiro, Brazil
  • ,
  • Ricardo Palmier Teles

      Affiliations

    • Department of Periodontology, The Forsyth Institute, Boston, MA, USA
  • ,
  • Ronir Raggio Luiz

      Affiliations

    • Institute of Public Health Studies, Federal University of Rio de Janeiro, Brazil
  • ,
  • Lucianne Cople Maia

      Affiliations

    • Department of Paediatric Dentistry and Orthodontics, School of Dentistry, Federal University of Rio de Janeiro, Brazil

Received 25 January 2009 ,Revised 13 August 2009 ,Accepted 8 September 2009.

References 

  1. Coogan MM, Sweet SP, Challacombe SJ. Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infection and Immunity. 1994;62:892–896
  2. Grimoud AM, Arnaud C, Dellamonica P, Lodter JP. Salivary defence factor concentrations in relation to oral and general parameters in HIV positive patients. European Journal of Oral Sciences. 1998;106:979–985
  3. Ramos-Gomez FJ, Petru A, Hilton JF, Canchola AJ, Wara D, Greenspan JS. Oral manifestations and dental status in paediatric HIV infection. International Journal of Paediatric Dentistry. 2000;10:3–11
  4. Barasch A, Safford MM, Catalanotto FA, Fine DH, Katz RV. Oral soft tissue manifestation in HIV-positive vs HIV-negative children from an inner city population: a two-year observational study. Pediatric Dentistry. 2000;22:215–220
  5. Fonseca R, Cardoso AS, Pomarico I. Frequency of oral manifestations in children infected with human immunodeficiency virus. Quintessence International. 2000;31:419–422
  6. Grando LJ, Yurgel LS, Machado DC, Silva CL, Menezes M, Picolli C. Manifestações estomatológicas, contagem de linfócitos T-CD4+ e carga viral de crianças brasileiras e norte-americanas infectadas pelo HIV. Pesquisa Odontológica Brasileira. 2002;16:18–25
  7. Mandel ID. The role of saliva in maintaining oral homeostasis. Journal of the American Dental Association. 1989;119:298–304
  8. Fubara ES, Freter R. Protection against enteric bacterial infection by secretory IgA antibodies. Journal of Immunology. 1973;111:395–403
  9. Svanborg-Eden C, Svennerholm AM. Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells. Infection and Immunity. 1978;22:790–797
  10. Epstein JB, Kimura LH, Menard TW, Truelove EL, Pearsall NN. Effects of specific antibodies on the interaction between the fungus Candida albicans and human oral mucosa. Archives of Oral Biology. 1982;17:469–474
  11. Vudhichamnong K, Walker DM, Ryley HC. The effect of secretory immunoglobulin A on the in-vitro adherence of the yeast Candida albicans to human oral epithelial cells. Archives of Oral Biology. 1982;27:617–621
  12. Wray D, Felix DH, Cumming CG. Alteration of humoral responses to Candida in HIV infection. British Dental Journal. 1990;168:326–329
  13. Costa CR, de Lemos JA, Passos XS, Araújo CR, Cohen AJ, Souza LK, et al. Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era. Mycopathologia. 2006;162:45–50
  14. Sánchez-Vargas LO, Ortiz-López NG, Villar M, Moragues MD, Aguirre JM, Cashat-Cruz M, et al. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons. Revista Iberoamericana de Micología. 2005;22:83–92
  15. Drobacheff C, Millon L, Monod M, Piarroux R, Robinet E, Laurent R, et al. Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis. Clinical Chemistry and Laboratory Medicine. 2001;39:519–526
  16. Sweet SP, Challacombe SJ, Naglik JR. Whole and parotid saliva IgA and IgA-subclass responses to Candida albicans in HIV infection. Advances in Experimental Medicine and Biology. 1995;371B:1031–1034
  17. Wozniak KL, Leigh JE, Hager S, Swoboda RK, Fidel PL. A comprehensive study of Candida-specific antibodies in the saliva of human immunodeficiency virus-positive individuals with oropharyngeal candidiasis. The Journal of Infectious Diseases. 2002;185:1269–1276
  18. Atkinson JC, Yeh C, Oppenheim FG, Bermudez D, Baum BJ, Fox PC. Elevation of salivary antimicrobial proteins following HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes. 1990;3:41–48
  19. Millon L, Drobacheff C, Piarroux R, Monod M, Reboux G, Laurent R, et al. Longitudinal study of anti-Candida albicans mucosal immunity against aspartic proteinases in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes. 2001;26:137–144
  20. Challacombe SJ. Immunologic aspects of oral candidiasis. Oral Surgery, Oral Medicine, and Oral Pathology. 1994;78:202–210
  21. Lin AL, Johnson DA, Patterson TF, Wu Y, Lu DL, Shi Q, et al. Salivary anticandidal activity and saliva composition in an HIV-infected cohort. Oral Microbiology and Immunology. 2001;16:270–278
  22. Namikoshi S, Ohshima T, Chiba H, Maeda N. Relationship between oral Candida and salivary antimicrobial proteins in HIV-positive individuals. Journal of Tokyo Medical University. 2004;62:625–634
  23. Belazi M, Fleva A, Drakoulakos D, Panayiotidou D. Salivary IgA and serum IgA and IgG antibodies to Candida albicans in HIV-infected subjects. International Journal of STD & AIDS. 2002;13:373–377
  24. Pomarico L, Cerqueira DF, Soares RMA, Souza IPR, Castro GFBA, Socransky S, et al. Associations among the use of highly active antiretroviral therapy, oral candidiasis, oral Candida species and salivary immunoglobulin A in HIV-infected children. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 2009;108:203–210
  25. Hamza OJM, Matee MIN, Simon ENM, Kikwilu E, Moshi MJ, Mugusi F, et al. Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. BMC Oral Health. 2006;6:1–9
  26. Miziara ID, Araújo Filho BC, Weber R. Oral lesions in brazilian HIV-infected children undergoing HAART. International Journal of Pediatric Otorhinolaryngology. 2006;70:1089–1096
  27. Greenspan JS, Greenspan D. The epidemiology of the oral lesions of HIV infection in the developed world. Oral Diseases. 2002;8:34–39
  28. Gaitán-Cepeda L, Cashat-Cruz M, Morales-Aguirre JJ, Sánchez-Vargas L, Aquino-Garcia S, Fragoso-Ríos R, et al. Prevalence of oral lesions in Mexican children with perinatally acquired HIV: association with immunologic status, viral load, and gender. AIDS Patient Care STDS. 2002;16:151–156
  29. Soares LF, Castro GFBA, Souza IPR, Pinheiro M. Pediatric HIV-related oral manifestations—a five-year retrospective study. Brazilian Oral Research. 2004;18:6–11
  30. Bektic J, Lell CP, Fuchs A, Stoiber H, Speth C, Lass-Flörl C, et al. HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro. FEMS Immunology and Medical Microbiology. 2001;31:65–71
  31. Bard E, Laibe S, Clair S, Biichlé S, Millon L, Drobacheff C, et al. Nonspecific secretory immunity in HIV-infected patients with oral candidiasis. Journal of Acquired Immune Deficiency Syndromes. 2002;31:276–284
  32. Castro GF, Souza IPR, Lopes S, Stashenko P, Teles RP. Salivary IgA to cariogenic bacteria in HIV-positive children and its correlation with caries prevalence and levels of cariogenic microorganisms. Oral Microbiology and Immunology. 2004;19:1–8

PII: S0300-5712(09)00213-9

doi: 10.1016/j.jdent.2009.09.005

Journal of Dentistry
Volume 38, Issue 1 , Pages 10-15 , January 2010